Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Salud Mental (102)

2024

  1. A Systematic Review of the Molecular and Cellular Alterations Induced by Cannabis That May Serve as Risk Factors for Bipolar Disorder

    The international journal of neuropsychopharmacology, Vol. 27, Núm. 2

  2. Consensus on the detection and management of patients with depression and pain as an associated somatic symptom

    Spanish Journal of Psychiatry and Mental Health

  3. Factors associated with high and low mental well-being in Spanish university students

    Journal of Affective Disorders, Vol. 356, pp. 424-435

  4. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 267, pp. 24-31

  5. N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia

    Translational Psychiatry, Vol. 14, Núm. 1

  6. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

    Spanish Journal of Psychiatry and Mental Health

  7. Suicidal ideation risk among LGB Spanish university students: The role of childhood and adolescence adversities and mental disorders

    Journal of Affective Disorders, Vol. 353, pp. 52-59

  8. THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation

    Psychiatry Research, Vol. 331

2023

  1. Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up

    International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807

  2. Cardiovascular-related proteomic changes in ECFCs exposed to the serum of COVID-19 patients

    International Journal of Biological Sciences, Vol. 19, Núm. 6, pp. 1664-1680

  3. Chemogenetic activation of locus coeruleus neurons ameliorates the severity of multiple sclerosis

    Journal of Neuroinflammation, Vol. 20, Núm. 1

  4. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients

    Revista de Psiquiatria y Salud Mental

  5. Massive Neonatal Arterial Ischemic Stroke

    Pediatric Neurology, Vol. 144, pp. 5-10

  6. Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations

    Schizophrenia Research

  7. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study

    European Neuropsychopharmacology, Vol. 67, pp. 53-65

  8. Sexual differences in locus coeruleus neurons and related behavior in C57BL/6J mice

    Biology of Sex Differences, Vol. 14, Núm. 1

  9. Shared decision making with schizophrenic patients: a randomized controlled clinical trial with booster sessions (DECIDE Study)

    Patient Education and Counseling, Vol. 110

  10. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

2022

  1. Altered expression of vesicular glutamate transporter-2 and cleaved caspase-3 in the locus coeruleus of nerve-injured rats

    Frontiers in Molecular Neuroscience, Vol. 15

  2. Epigenetic clocks in relapse after a first episode of schizophrenia

    Schizophrenia, Vol. 8, Núm. 1